BPC-157 + TB-500 blend vs TB-500

Name: BPC-157 + TB-500 blend vs TB-500
Published: 2026-10-24

Updated Oct 24, 20268 sources

Key differences

1Separate TB-500 allows a 4 to 5 mg weekly loading phase. A 1:1 daily blend delivers about 3.5 mg a week at 500 mcg of BPC-157 a day.

Facts from each record, in the same words as their own pages.

BPC-157 + TB-500 blend and TB-500 side by side
	BPC-157 + TB-500 blend	TB-500
Category	Healing & recovery	Healing & recovery
Evidence	No human trials	Animal data only
FDA status	Not FDA approvedRegulatory	Not FDA approvedRegulatory
WADA	Prohibited	Prohibited
Half-life	No value for the blend. BPC-157 clears in under 30 minutes in rats and dogs. The TB-500 fragment has no human value; full-length thymosin beta-4 by IV lasted longer at higher doses.Competitor guide	Not established in humans for the fragment. Full-length thymosin beta-4 by IV lasted longer at higher doses; one guide cites 0.5 to 2.1 hours.Clinical study
Routes	Subcutaneous injection	Subcutaneous injection, Intramuscular injection
Forms	Vial (powder)	Vial (powder)
Reported doses	250 to 1,500 mcg (subcutaneous injection) 0.5 to 2 mg (subcutaneous injection)	1 to 5 mg (subcutaneous injection) 2 to 2.5 mg (intramuscular injection) 500 to 1,000 mcg (subcutaneous injection)
Most cited frequency	Once daily	Twice weekly
Vial sizes	10 mg, 20 mgCompetitor guide	2 mg, 5 mg, 10 mgCompetitor guide
Mixed vial keeps	Fridge at 2 to 8 C, never frozen.Competitor guide	Fridge at 2 to 8 C, dark, never frozen.Competitor guide
Protocols on file	8	19

Doses shown are what sources report, labelled by origin. Not medical advice.

8 sources, each checked by date. Record updated Oct 24, 2026. Numbers are restated in our own words and labelled by where they came from.